Cordance Medical, a pioneer in noninvasive focused ultrasound technology for brain disease treatment, announced an oversubscribed seed financing round led by Sonder Capital. The round surpassed its $8M target and included participation from existing and new investors, including Shanda Grab Ventures, Angel Physician's Fund, SmartGateVC, and R42.

Cordance Medical是一家致力于脑部疾病治疗的非侵入性聚焦超声技术的先驱企业，宣布由Sonder Capital领投的超额认购种子轮融资。本轮融资超出其800万美元的目标，并获得了包括盛大创投、天使医生基金、SmartGateVC和R42在内的现有投资者和新投资者的参与。

The Sontag Foundation Innovation Fund, a subsidiary of The Sontag Foundation, and the Brain Tumor Investment Fund, a venture subsidiary of the National Brain Tumor Society, also joined the round, highlighting the platform's potential impact on neuro-oncology care..

Sontag基金会的子公司Sontag基金会创新基金和国家脑肿瘤协会的风险投资子公司脑肿瘤投资基金也参与了此轮融资，突显了该平台在神经肿瘤治疗领域的潜在影响。